Showing 1 - 5 results of 5 for search 'Gianluca Ametrano', query time: 0.03s Refine Results
  1. 1
    Growth, Anatomical, and Biochemical Responses of the Space Farming Candidate <i>Brassica rapa</i> L. Microgreens to Low-LET Ionizing Radiation

    Growth, Anatomical, and Biochemical Responses of the Space Farming Candidate <i>Brassica rapa</i> L. Microgreens to Low-LET Ionizing Radiation by Sara De Francesco, Chiara Amitrano, Ermenegilda Vitale, Giulia Costanzo, Mariagabriella Pugliese, Cecilia Arrichiello, Gianluca Ametrano, Paolo Muto, Carmen Arena, Veronica De Micco

    Published 2023-04-01
    Get full text
    Article
  2. 2
    SBRT for Localized Prostate Cancer: CyberKnife vs. VMAT-FFF, a Dosimetric Study

    SBRT for Localized Prostate Cancer: CyberKnife vs. VMAT-FFF, a Dosimetric Study by Marcello Serra, Fortuna De Martino, Federica Savino, Valentina D’Alesio, Cecilia Arrichiello, Maria Quarto, Filomena Loffredo, Rossella Di Franco, Valentina Borzillo, Matteo Muto, Gianluca Ametrano, Paolo Muto

    Published 2022-05-01
    Get full text
    Article
  3. 3
    Reirradiation of Locally Recurrent Prostate Cancer with Cyberknife<sup>®</sup> System or Volumetric Modulated Arc Therapy (VMAT) and IGRT-Clarity<sup>®</sup>: Outcomes, Toxicities and Dosimetric Evaluation

    Reirradiation of Locally Recurrent Prostate Cancer with Cyberknife<sup>®</sup> System or Volumetric Modulated Arc Therapy (VMAT) and IGRT-Clarity<sup>®</sup>: Outcomes, Toxicities... by Rossella Di Franco, Valentina Borzillo, Esmeralda Scipilliti, Gianluca Ametrano, Marcello Serra, Cecilia Arrichiello, Federica Savino, Fortuna De Martino, Valentina D’Alesio, Fabrizio Cammarota, Anna Crispo, Sandro Pignata, Sabrina Rossetti, Giuseppe Quarto, Paolo Muto

    Published 2022-06-01
    Get full text
    Article
  4. 4
    Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial

    Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial by Valentina Borzillo, Esmeralda Scipilliti, Donato Pezzulla, Marcello Serra, Gianluca Ametrano, Giuseppe Quarto, Sisto Perdonà, Sabrina Rossetti, Sandro Pignata, Anna Crispo, Piergiacomo Di Gennaro, Valentina D’Alesio, Cecilia Arrichiello, Francesca Buonanno, Simona Mercogliano, Antonio Russo, Antonio Tufano, Rossella Di Franco, Paolo Muto

    Published 2023-11-01
    Get full text
    Article
  5. 5
    Prospective Evaluation of Radiotherapy-Induced Immunologic and Genetic Effects in Colorectal Cancer Oligo-Metastatic Patients with Lung-Limited Disease: The PRELUDE-1 Study

    Prospective Evaluation of Radiotherapy-Induced Immunologic and Genetic Effects in Colorectal Cancer Oligo-Metastatic Patients with Lung-Limited Disease: The PRELUDE-1 Study by Alessandro Ottaiano, Angela Petito, Mariachiara Santorsola, Valerio Gigantino, Maurizio Capuozzo, Daniela Fontanella, Rossella Di Franco, Valentina Borzillo, Sergio Buonopane, Vincenzo Ravo, Esmeralda Scipilliti, Giuseppe Totaro, Marcello Serra, Gianluca Ametrano, Roberta Penta, Fabiana Tatangelo, Giosuè Scognamiglio, Annabella Di Mauro, Maurizio Di Bonito, Maria Napolitano, Stefania Scala, Giuseppina Rea, Sara Santagata, Angela Lombardi, Anna Grimaldi, Carlo Caputo, Anna Crispo, Egidio Celentano, Gianfranco De Feo, Luisa Circelli, Giovanni Savarese, Raffaella Ruggiero, Francesco Perri, Vincenza Granata, Gerardo Botti, Michele Caraglia, Guglielmo Nasti, Paolo Muto

    Published 2021-08-01
    Get full text
    Article

Search Tools: